IMP
Process View
cellular response to hydrogen peroxide
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "cellular response to hydrogen peroxide"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.997 | Human | |
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.997 | ||
| HBB | hemoglobin, beta | 0.964 | ||
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.928 | Human | |
| PRDX1 | peroxiredoxin 1 | 0.920 | ||
| REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.915 | Human | |
| JUN | jun proto-oncogene | 0.888 | ||
| HBA2 | hemoglobin, alpha 2 | 0.856 | ||
| GAPDH | glyceraldehyde-3-phosphate dehydrogenase | 0.769 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.755 | Rat | |
| MPDZ | multiple PDZ domain protein | 0.733 | ||
| MAFG | v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian) | 0.708 | ||
| PRDX4 | peroxiredoxin 4 | 0.696 | Human Worm | |
| BCL3 | B-cell CLL/lymphoma 3 | 0.657 | ||
| HBG2 | hemoglobin, gamma G | 0.645 | ||
| SOD1 | superoxide dismutase 1, soluble | 0.615 | ||
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.599 | ||
| DAXX | death-domain associated protein | 0.591 | ||
| PLAU | plasminogen activator, urokinase | 0.539 | Human | |
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.448 | ||
| EGFR | epidermal growth factor receptor | 0.420 | ||
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.414 | ||
| TXN | thioredoxin | 0.404 | ||
| ARHGAP1 | Rho GTPase activating protein 1 | 0.387 | ||
| DUSP1 | dual specificity phosphatase 1 | 0.386 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.340 | ||
| MAPT | microtubule-associated protein tau | 0.307 | ||
| PRDX2 | peroxiredoxin 2 | 0.300 | Human Mouse Worm | |
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.300 | ||
| NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 | 0.292 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.271 | ||
| PPP1R15A | protein phosphatase 1, regulatory (inhibitor) subunit 15A | 0.267 | ||
| TNFAIP1 | tumor necrosis factor, alpha-induced protein 1 (endothelial) | 0.262 | ||
| IL4R | interleukin 4 receptor | 0.251 | ||
| KLF6 | Kruppel-like factor 6 | 0.239 | Rat | |
| PRKAB1 | protein kinase, AMP-activated, beta 1 non-catalytic subunit | 0.234 | ||
| RHOA | ras homolog gene family, member A | 0.229 | Human | |
| GAB1 | GRB2-associated binding protein 1 | 0.220 | ||
| ACACA | acetyl-CoA carboxylase alpha | 0.208 | ||
| PARK7 | Parkinson disease (autosomal recessive, early onset) 7 | 0.194 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.193 | ||
| PML | promyelocytic leukemia | 0.193 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.185 | ||
| ATF3 | activating transcription factor 3 | 0.185 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.172 | ||
| TSC22D4 | TSC22 domain family, member 4 | 0.160 | ||
| RUNX1 | runt-related transcription factor 1 | 0.158 | ||
| TTR | transthyretin | 0.157 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.151 | ||
| TNIP2 | TNFAIP3 interacting protein 2 | 0.151 | ||
| APOE | apolipoprotein E | 0.146 | ||
| RING1 | ring finger protein 1 | 0.144 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.143 | ||
| GPX4 | glutathione peroxidase 4 (phospholipid hydroperoxidase) | 0.139 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.135 | ||
| FBXO7 | F-box protein 7 | 0.135 | ||
| S100B | S100 calcium binding protein B | 0.123 | ||
| EP300 | E1A binding protein p300 | 0.121 | ||
| HP | haptoglobin | 0.118 | ||
| AR | androgen receptor | 0.110 | ||
| PTPN13 | protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) | 0.107 | ||
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.103 | ||
| FADD | Fas (TNFRSF6)-associated via death domain | 0.101 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.100 | ||
| COL4A2 | collagen, type IV, alpha 2 | 0.096 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.091 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.091 | ||
| PLXNB1 | plexin B1 | 0.090 | ||
| PRKAB2 | protein kinase, AMP-activated, beta 2 non-catalytic subunit | 0.086 | ||
| CTSD | cathepsin D | 0.086 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.083 | ||
| PGK1 | phosphoglycerate kinase 1 | 0.082 | ||
| KLF4 | Kruppel-like factor 4 (gut) | 0.079 | Rat | |
| IL6R | interleukin 6 receptor | 0.078 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.077 | ||
| TSPO | translocator protein (18kDa) | 0.075 | ||
| PGAM1 | phosphoglycerate mutase 1 (brain) | 0.074 | ||
| PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | 0.074 | ||
| LCAT | lecithin-cholesterol acyltransferase | 0.071 | ||
| JUND | jun D proto-oncogene | 0.071 | ||
| HBE1 | hemoglobin, epsilon 1 | 0.070 | ||
| TNIP1 | TNFAIP3 interacting protein 1 | 0.070 | ||
| PRDX6 | peroxiredoxin 6 | 0.069 | Rat | |
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.069 | ||
| TPP1 | tripeptidyl peptidase I | 0.069 | ||
| FOXO1 | forkhead box O1 | 0.069 | ||
| DUSP23 | dual specificity phosphatase 23 | 0.069 | ||
| PLAT | plasminogen activator, tissue | 0.069 | Human | |
| KEAP1 | kelch-like ECH-associated protein 1 | 0.067 | ||
| PRKAG1 | protein kinase, AMP-activated, gamma 1 non-catalytic subunit | 0.064 | ||
| APOA1 | apolipoprotein A-I | 0.063 | Human | |
| C3 | complement component 3 | 0.060 | ||
| CREBBP | CREB binding protein | 0.058 | ||
| CCND2 | cyclin D2 | 0.058 | ||
| APOC3 | apolipoprotein C-III | 0.057 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.055 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.055 | Human | |
| PRMT2 | protein arginine methyltransferase 2 | 0.054 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.054 | Rat | |
| HBD | hemoglobin, delta | 0.053 | ||
| DAD1 | defender against cell death 1 | 0.053 | ||
| PDIA6 | protein disulfide isomerase family A, member 6 | 0.051 | ||
| ALB | albumin | 0.049 | ||
| RHOB | ras homolog gene family, member B | 0.049 | ||
| HSPA1B | heat shock 70kDa protein 1B | 0.048 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.048 | ||
| OS9 | osteosarcoma amplified 9, endoplasmic reticulum lectin | 0.046 | ||
| IL4 | interleukin 4 | 0.046 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.045 | ||
| MAP2K5 | mitogen-activated protein kinase kinase 5 | 0.044 | ||
| ATF2 | activating transcription factor 2 | 0.044 | ||
| GADD45B | growth arrest and DNA-damage-inducible, beta | 0.044 | ||
| DAB2IP | DAB2 interacting protein | 0.044 | ||
| CFHR1 | complement factor H-related 1 | 0.043 | ||
| EHHADH | enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase | 0.043 | ||
| FGB | fibrinogen beta chain | 0.042 | ||
| CKS2 | CDC28 protein kinase regulatory subunit 2 | 0.042 | ||
| PRKAG2 | protein kinase, AMP-activated, gamma 2 non-catalytic subunit | 0.042 | ||
| HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.041 | ||
| MAP2K7 | mitogen-activated protein kinase kinase 7 | 0.041 | ||
| ARRB1 | arrestin, beta 1 | 0.041 | ||
| CBX8 | chromobox homolog 8 | 0.040 | ||
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.040 | Rat | |
| FOSL2 | FOS-like antigen 2 | 0.039 | ||
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.038 | ||
| ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) | 0.038 | ||
| OR2AG1 | olfactory receptor, family 2, subfamily AG, member 1 | 0.037 | ||
| ESR1 | estrogen receptor 1 | 0.037 | ||
| ARID4B | AT rich interactive domain 4B (RBP1-like) | 0.037 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.036 | ||
| TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | 0.036 | ||
| APLP2 | amyloid beta (A4) precursor-like protein 2 | 0.035 | ||
| HTR2C | 5-hydroxytryptamine (serotonin) receptor 2C | 0.035 | ||
| RAB5B | RAB5B, member RAS oncogene family | 0.035 | ||
| TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.034 | ||
| PRDX3 | peroxiredoxin 3 | 0.034 | ||
| BBS1 | Bardet-Biedl syndrome 1 | 0.034 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.034 | ||
| CLU | clusterin | 0.034 | ||
| BACH1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 | 0.034 | Human | |
| CTSB | cathepsin B | 0.033 | ||
| EMP1 | epithelial membrane protein 1 | 0.033 | ||
| PTRF | polymerase I and transcript release factor | 0.033 | ||
| ARHGEF7 | Rho guanine nucleotide exchange factor (GEF) 7 | 0.033 | ||
| SP100 | SP100 nuclear antigen | 0.032 | ||
| UHRF1 | ubiquitin-like with PHD and ring finger domains 1 | 0.032 | ||
| HSD17B4 | hydroxysteroid (17-beta) dehydrogenase 4 | 0.032 | ||
| ADAMTSL4 | ADAMTS-like 4 | 0.032 | ||
| PRKCA | protein kinase C, alpha | 0.031 | ||
| ALAS2 | aminolevulinate, delta-, synthase 2 | 0.031 | ||
| GSN | gelsolin | 0.031 | ||
| VHL | von Hippel-Lindau tumor suppressor | 0.030 | ||
| ADRBK1 | adrenergic, beta, receptor kinase 1 | 0.029 | ||
| ORM1 | orosomucoid 1 | 0.029 | ||
| SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 0.028 | ||
| MAP2K3 | mitogen-activated protein kinase kinase 3 | 0.028 | ||
| MAPK8IP1 | mitogen-activated protein kinase 8 interacting protein 1 | 0.028 | ||
| DDIT3 | DNA-damage-inducible transcript 3 | 0.028 | ||
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.028 | ||
| FRS2 | fibroblast growth factor receptor substrate 2 | 0.027 | ||
| TXNDC5 | thioredoxin domain containing 5 (endoplasmic reticulum) | 0.027 | ||
| PF4 | platelet factor 4 | 0.027 | ||
| GCGR | glucagon receptor | 0.027 | ||
| OAZ1 | ornithine decarboxylase antizyme 1 | 0.026 | ||
| INSR | insulin receptor | 0.026 | ||
| NFKBIB | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta | 0.026 | ||
| NCOA2 | nuclear receptor coactivator 2 | 0.025 | ||
| SMARCB1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | 0.025 | ||
| SNCAIP | synuclein, alpha interacting protein | 0.025 | ||
| MAP3K7 | mitogen-activated protein kinase kinase kinase 7 | 0.025 | ||
| MAP2K6 | mitogen-activated protein kinase kinase 6 | 0.024 | ||
| JUNB | jun B proto-oncogene | 0.024 | ||
| KLF1 | Kruppel-like factor 1 (erythroid) | 0.024 | ||
| HBQ1 | hemoglobin, theta 1 | 0.024 | Human | |
| HADHB | hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit | 0.023 | ||
| MAVS | mitochondrial antiviral signaling protein | 0.023 | ||
| RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.023 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.023 | ||
| GRPEL1 | GrpE-like 1, mitochondrial (E. coli) | 0.023 | ||
| ZBED1 | zinc finger, BED-type containing 1 | 0.023 | ||
| MAFK | v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian) | 0.023 | ||
| RANBP9 | RAN binding protein 9 | 0.023 | ||
| RBPMS | RNA binding protein with multiple splicing | 0.023 | ||
| YWHAB | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide | 0.023 | ||
| RGS2 | regulator of G-protein signaling 2, 24kDa | 0.022 | ||
| BABAM1 | BRISC and BRCA1 A complex member 1 | 0.022 | ||
| HSPA1A | heat shock 70kDa protein 1A | 0.022 | ||
| USP11 | ubiquitin specific peptidase 11 | 0.022 | ||
| NPC2 | Niemann-Pick disease, type C2 | 0.022 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.022 | ||
| CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.021 | ||
| EFEMP2 | EGF containing fibulin-like extracellular matrix protein 2 | 0.021 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.021 | ||
| GGH | gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) | 0.021 | ||
| IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.021 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.021 | ||
| PARK2 | parkinson protein 2, E3 ubiquitin protein ligase (parkin) | 0.021 | ||
| AMBP | alpha-1-microglobulin/bikunin precursor | 0.020 | ||
| MAP1LC3B | microtubule-associated protein 1 light chain 3 beta | 0.020 | ||
| LZTS2 | leucine zipper, putative tumor suppressor 2 | 0.020 | ||
| CDK2AP2 | cyclin-dependent kinase 2 associated protein 2 | 0.020 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.020 | ||
| MAP1B | microtubule-associated protein 1B | 0.020 | ||
| APOC1 | apolipoprotein C-I | 0.020 | ||
| HAGH | hydroxyacylglutathione hydrolase | 0.019 | ||
| EHD1 | EH-domain containing 1 | 0.019 | ||
| HBZ | hemoglobin, zeta | 0.019 | Human | |
| GABARAP | GABA(A) receptor-associated protein | 0.019 | ||
| MARK4 | MAP/microtubule affinity-regulating kinase 4 | 0.019 | ||
| MAPK14 | mitogen-activated protein kinase 14 | 0.019 | ||
| FOXO3 | forkhead box O3 | 0.019 | ||
| SPHK1 | sphingosine kinase 1 | 0.019 | Rat | |
| FAM65A | family with sequence similarity 65, member A | 0.019 | ||
| GYPB | glycophorin B (MNS blood group) | 0.019 | ||
| SSTR3 | somatostatin receptor 3 | 0.019 | ||
| LITAF | lipopolysaccharide-induced TNF factor | 0.019 | ||
| CTTN | cortactin | 0.019 | ||
| AHR | aryl hydrocarbon receptor | 0.019 | ||
| CTSL1 | cathepsin L1 | 0.019 | ||
| TMEM173 | transmembrane protein 173 | 0.018 | ||
| KCTD17 | potassium channel tetramerisation domain containing 17 | 0.018 | ||
| DAPK1 | death-associated protein kinase 1 | 0.018 | ||
| RHOXF2 | Rhox homeobox family, member 2 | 0.018 | ||
| PGLYRP1 | peptidoglycan recognition protein 1 | 0.018 | ||
| VDAC1 | voltage-dependent anion channel 1 | 0.018 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.018 | ||
| HSPA8 | heat shock 70kDa protein 8 | 0.017 | ||
| LRDD | leucine-rich repeats and death domain containing | 0.017 | ||
| CD320 | CD320 molecule | 0.017 | ||
| TMOD3 | tropomodulin 3 (ubiquitous) | 0.017 | ||
| GSTO1 | glutathione S-transferase omega 1 | 0.017 | ||
| FOSL1 | FOS-like antigen 1 | 0.017 | ||
| EIF2AK3 | eukaryotic translation initiation factor 2-alpha kinase 3 | 0.017 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.017 | ||
| VTN | vitronectin | 0.017 | ||
| TPPP | tubulin polymerization promoting protein | 0.017 | ||
| ELANE | elastase, neutrophil expressed | 0.017 | ||
| PRTN3 | proteinase 3 | 0.017 | ||
| SPAG9 | sperm associated antigen 9 | 0.017 | ||
| DNMT3B | DNA (cytosine-5-)-methyltransferase 3 beta | 0.016 | ||
| MVP | major vault protein | 0.016 | ||
| FHL2 | four and a half LIM domains 2 | 0.016 | ||
| SYN1 | synapsin I | 0.016 | ||
| ABI1 | abl-interactor 1 | 0.016 | ||
| FGA | fibrinogen alpha chain | 0.016 | ||
| ETS2 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) | 0.016 | ||
| BANP | BTG3 associated nuclear protein | 0.016 | ||
| MYL4 | myosin, light chain 4, alkali; atrial, embryonic | 0.016 | ||
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.016 | ||
| TGIF1 | TGFB-induced factor homeobox 1 | 0.016 | ||
| NFE2L1 | nuclear factor (erythroid-derived 2)-like 1 | 0.016 | Human | |
| CSRNP1 | cysteine-serine-rich nuclear protein 1 | 0.016 | ||
| RETN | resistin | 0.016 | ||
| NFATC2 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 | 0.016 | ||
| SLC4A1 | solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group) | 0.016 | ||
| FTCD | formiminotransferase cyclodeaminase | 0.016 | ||
| GAA | glucosidase, alpha; acid | 0.016 | ||
| EED | embryonic ectoderm development | 0.015 | ||
| BID | BH3 interacting domain death agonist | 0.015 | ||
| TXNDC2 | thioredoxin domain containing 2 (spermatozoa) | 0.015 | ||
| GATA1 | GATA binding protein 1 (globin transcription factor 1) | 0.015 | ||
| ETS1 | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) | 0.015 | Rat | |
| PHF1 | PHD finger protein 1 | 0.015 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.015 | ||
| AZU1 | azurocidin 1 | 0.015 | ||
| CFI | complement factor I | 0.015 | ||
| CTSG | cathepsin G | 0.015 | ||
| PTPN5 | protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) | 0.015 | ||
| WBP2 | WW domain binding protein 2 | 0.015 | ||
| SPRR2A | small proline-rich protein 2A | 0.015 | ||
| THBS1 | thrombospondin 1 | 0.015 | ||
| SPTBN1 | spectrin, beta, non-erythrocytic 1 | 0.014 | ||
| CBX2 | chromobox homolog 2 | 0.014 | ||
| KCTD3 | potassium channel tetramerisation domain containing 3 | 0.014 | ||
| ARHGDIA | Rho GDP dissociation inhibitor (GDI) alpha | 0.014 | ||
| CDKN2C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | 0.014 | ||
| TGFB1I1 | transforming growth factor beta 1 induced transcript 1 | 0.014 | ||
| CAV2 | caveolin 2 | 0.014 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.014 | ||
| RRAS | related RAS viral (r-ras) oncogene homolog | 0.014 | ||
| FTH1 | ferritin, heavy polypeptide 1 | 0.014 | ||
| TBXA2R | thromboxane A2 receptor | 0.014 | ||
| F2 | coagulation factor II (thrombin) | 0.014 | ||
| EEF2 | eukaryotic translation elongation factor 2 | 0.014 | ||
| TALDO1 | transaldolase 1 | 0.014 | ||
| THBD | thrombomodulin | 0.014 | ||
| NCOA4 | nuclear receptor coactivator 4 | 0.014 | ||
| GHR | growth hormone receptor | 0.014 | ||
| FAM107A | family with sequence similarity 107, member A | 0.014 | ||
| SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.014 | ||
| RNASEK | ribonuclease, RNase K | 0.014 | ||
| IL1R1 | interleukin 1 receptor, type I | 0.014 | ||
| SMAD1 | SMAD family member 1 | 0.014 | ||
| LBP | lipopolysaccharide binding protein | 0.014 | ||
| IRS2 | insulin receptor substrate 2 | 0.014 | ||
| TP53 | tumor protein p53 | 0.014 | ||
| KLF2 | Kruppel-like factor 2 (lung) | 0.014 | Rat | |
| CCND3 | cyclin D3 | 0.014 | ||
| TFRC | transferrin receptor (p90, CD71) | 0.014 | ||
| APP | amyloid beta (A4) precursor protein | 0.014 | ||
| HOXA1 | homeobox A1 | 0.013 | ||
| TSC22D3 | TSC22 domain family, member 3 | 0.013 | ||
| PDLIM4 | PDZ and LIM domain 4 | 0.013 | ||
| VEGFC | vascular endothelial growth factor C | 0.013 | ||
| IER2 | immediate early response 2 | 0.013 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.013 | ||
| HADH | hydroxyacyl-CoA dehydrogenase | 0.013 | ||
| SERPINF2 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 | 0.013 | ||
| CYLD | cylindromatosis (turban tumor syndrome) | 0.013 | ||
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.013 | ||
| CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 0.013 | ||
| GPLD1 | glycosylphosphatidylinositol specific phospholipase D1 | 0.013 | ||
| TUBB6 | tubulin, beta 6 | 0.013 | ||
| PLTP | phospholipid transfer protein | 0.013 | ||
| IRS1 | insulin receptor substrate 1 | 0.013 | ||
| PDZK1IP1 | PDZK1 interacting protein 1 | 0.013 | ||
| EPHX1 | epoxide hydrolase 1, microsomal (xenobiotic) | 0.013 | ||
| WASF1 | WAS protein family, member 1 | 0.013 | ||
| CTSA | cathepsin A | 0.013 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.013 | ||
| C13orf15 | chromosome 13 open reading frame 15 | 0.013 | ||
| S1PR1 | sphingosine-1-phosphate receptor 1 | 0.013 | ||
| ING2 | inhibitor of growth family, member 2 | 0.013 | ||
| CD63 | CD63 molecule | 0.013 | ||
| PRDX5 | peroxiredoxin 5 | 0.013 | ||
| SPSB1 | splA/ryanodine receptor domain and SOCS box containing 1 | 0.013 | ||
| HEXB | hexosaminidase B (beta polypeptide) | 0.013 | ||
| CAMP | cathelicidin antimicrobial peptide | 0.013 | ||
| TFR2 | transferrin receptor 2 | 0.013 | ||
| AMT | aminomethyltransferase | 0.013 | ||
| TUBA1A | tubulin, alpha 1a | 0.013 | ||
| DYNLL1 | dynein, light chain, LC8-type 1 | 0.013 | ||
| FIS1 | fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae) | 0.012 | ||
| ABI2 | abl-interactor 2 | 0.012 | ||
| FAM127A | family with sequence similarity 127, member A | 0.012 | ||
| FSTL3 | follistatin-like 3 (secreted glycoprotein) | 0.012 | ||
| ZBTB7B | zinc finger and BTB domain containing 7B | 0.012 | ||
| HBEGF | heparin-binding EGF-like growth factor | 0.012 | ||
| CMIP | c-Maf-inducing protein | 0.012 | ||
| NME4 | non-metastatic cells 4, protein expressed in | 0.012 | ||
| NBN | nibrin | 0.012 | ||
| CELSR1 | cadherin, EGF LAG seven-pass G-type receptor 1 (flamingo homolog, Drosophila) | 0.012 | ||
| DUSP10 | dual specificity phosphatase 10 | 0.012 | ||
| DBI | diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) | 0.012 | ||
| NEDD8 | neural precursor cell expressed, developmentally down-regulated 8 | 0.012 | ||
| BAD | BCL2-associated agonist of cell death | 0.012 | ||
| CD81 | CD81 molecule | 0.012 | ||
| LAMP1 | lysosomal-associated membrane protein 1 | 0.012 | ||
| CA4 | carbonic anhydrase IV | 0.012 | ||
| CFD | complement factor D (adipsin) | 0.012 | ||
| DEFA4 | defensin, alpha 4, corticostatin | 0.012 | ||
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.012 | ||
| SERPINE2 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 | 0.012 | ||
| LTF | lactotransferrin | 0.012 | ||
| BHMT | betaine--homocysteine S-methyltransferase | 0.012 | ||
| SGK1 | serum/glucocorticoid regulated kinase 1 | 0.012 | ||
| CATSPER1 | cation channel, sperm associated 1 | 0.012 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.012 | ||
| AHSP | alpha hemoglobin stabilizing protein | 0.012 | ||
| IL8 | interleukin 8 | 0.012 | ||
| DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha | 0.012 | ||
| OAT | ornithine aminotransferase | 0.011 | ||
| PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | 0.011 | ||
| C8A | complement component 8, alpha polypeptide | 0.011 | ||
| IFNGR2 | interferon gamma receptor 2 (interferon gamma transducer 1) | 0.011 | ||
| GEM | GTP binding protein overexpressed in skeletal muscle | 0.011 | ||
| SIK1 | salt-inducible kinase 1 | 0.011 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.011 | ||
| SPTAN1 | spectrin, alpha, non-erythrocytic 1 (alpha-fodrin) | 0.011 | ||
| CLTA | clathrin, light chain A | 0.011 | ||
| PRAF2 | PRA1 domain family, member 2 | 0.011 | ||
| MS4A3 | membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific) | 0.011 | ||
| CAT | catalase | 0.011 | ||
| TNC | tenascin C | 0.011 | ||
| SELENBP1 | selenium binding protein 1 | 0.011 | ||
| CD55 | CD55 molecule, decay accelerating factor for complement (Cromer blood group) | 0.011 | ||
| BPI | bactericidal/permeability-increasing protein | 0.011 | ||
| PHC1 | polyhomeotic homolog 1 (Drosophila) | 0.011 | ||
| MPZL1 | myelin protein zero-like 1 | 0.011 | ||
| ESR2 | estrogen receptor 2 (ER beta) | 0.011 | ||
| ELF1 | E74-like factor 1 (ets domain transcription factor) | 0.011 | ||
| SPRY2 | sprouty homolog 2 (Drosophila) | 0.011 | ||
| ATP5G3 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9) | 0.011 | ||
| RAD52 | RAD52 homolog (S. cerevisiae) | 0.011 | ||
| FKBP5 | FK506 binding protein 5 | 0.011 | ||
| COL17A1 | collagen, type XVII, alpha 1 | 0.011 | ||
| MAPK10 | mitogen-activated protein kinase 10 | 0.011 | ||
| PRKAA2 | protein kinase, AMP-activated, alpha 2 catalytic subunit | 0.011 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.011 | ||
| BNIPL | BCL2/adenovirus E1B 19kD interacting protein like | 0.011 | ||
| EPB42 | erythrocyte membrane protein band 4.2 | 0.011 | ||
| ZNHIT1 | zinc finger, HIT-type containing 1 | 0.011 | ||
| CTSE | cathepsin E | 0.011 | ||
| S100P | S100 calcium binding protein P | 0.011 | ||
| SUCLG2 | succinate-CoA ligase, GDP-forming, beta subunit | 0.011 | ||
| RNF19B | ring finger protein 19B | 0.011 | ||
| ACTN1 | actinin, alpha 1 | 0.011 | ||
| INHBA | inhibin, beta A | 0.011 | ||
| C4BPB | complement component 4 binding protein, beta | 0.011 | ||
| SSR4 | signal sequence receptor, delta (translocon-associated protein delta) | 0.011 | ||
| MARCH2 | membrane-associated ring finger (C3HC4) 2 | 0.011 | ||
| ITCH | itchy E3 ubiquitin protein ligase homolog (mouse) | 0.011 | ||
| SPP2 | secreted phosphoprotein 2, 24kDa | 0.011 | ||
| PMEPA1 | prostate transmembrane protein, androgen induced 1 | 0.011 | ||
| DNTT | deoxynucleotidyltransferase, terminal | 0.010 | ||
| TERT | telomerase reverse transcriptase | 0.010 | ||
| ENO1 | enolase 1, (alpha) | 0.010 | ||
| STK11 | serine/threonine kinase 11 | 0.010 | ||
| LCOR | ligand dependent nuclear receptor corepressor | 0.010 | ||
| OSBP2 | oxysterol binding protein 2 | 0.010 | ||
| NCKAP1 | NCK-associated protein 1 | 0.010 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.010 | ||
| IGFBP4 | insulin-like growth factor binding protein 4 | 0.010 | ||
| APOB | apolipoprotein B (including Ag(x) antigen) | 0.010 | ||
| EGLN3 | egl nine homolog 3 (C. elegans) | 0.010 | ||
| DVL1 | dishevelled, dsh homolog 1 (Drosophila) | 0.010 | ||
| HAAO | 3-hydroxyanthranilate 3,4-dioxygenase | 0.010 | ||
| NFE2 | nuclear factor (erythroid-derived 2), 45kDa | 0.010 | Human | |
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.010 | ||
| TCN2 | transcobalamin II | 0.010 | ||
| GPSM1 | G-protein signaling modulator 1 | 0.010 | ||
| PDGFC | platelet derived growth factor C | 0.010 | ||
| HMOX1 | heme oxygenase (decycling) 1 | 0.010 | ||
| AK2 | adenylate kinase 2 | 0.010 | ||
| EZR | ezrin | 0.010 | ||
| FAM83C | family with sequence similarity 83, member C | 0.010 | ||
| FTL | ferritin, light polypeptide | 0.010 | ||
| DUSP5 | dual specificity phosphatase 5 | 0.010 | ||
| SLPI | secretory leukocyte peptidase inhibitor | 0.010 | ||
| FABP4 | fatty acid binding protein 4, adipocyte | 0.010 |